CLINICAL_TRIALS
trial_result
· 2025-10-22
Clinical Trial Update: A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation [Phase 2]
Summary
Phase 2 trial of fenofibrate to prevent ischemic cholangiopathy after liver transplantation was terminated. Results have been posted on 2025-10-22.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Liver Transplant | Phase 2 | Status: TERMINATED | Results posted: 2025-10-22